BioMarin Pharmaceutical Inc. buy Piper Sandler
Start price
20.02.25
/
50%
€68.34
Target price
20.02.26
€120.57
Performance (%)
-21.69%
End price
21.02.26
€53.52
Summary
This prediction ended on 21.02.26 with a price of €53.52. The prediction for BioMarin Pharmaceutical Inc. disappointed with a performance of -21.69%. Piper_Sandler has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -4.572% | -4.572% | -11.146% |
| iShares Core DAX® | 0,44 % | 3,03 % | 12,68 % |
| iShares Nasdaq 100 | 3,82 % | 4,07 % | 33,15 % |
| iShares Nikkei 225® | 1,15 % | 6,90 % | 45,49 % |
| iShares S&P 500 | 2,37 % | 2,68 % | 25,69 % |
Comments by Piper_Sandler for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target raised by analysts at Piper Sandler from $122.00 to $126.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Current prediction by Piper_Sandler for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€49.09
06.02.26
06.02.26
€71.25
06.02.27
06.02.27
-6.46%
16.04.26
16.04.26
Stopped prediction by Piper_Sandler for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€75.46
05.09.24
05.09.24
€109.96
05.09.25
05.09.25
-34.85%
06.09.25
06.09.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€80.88
27.08.24
27.08.24
€95.81
27.08.25
27.08.25
-38.16%
28.08.25
28.08.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€84.34
23.02.24
23.02.24
€98.83
23.02.25
23.02.25
-22.62%
24.02.25
24.02.25